KPV
An anti-inflammatory peptide fragment studied for gut and skin-related inflammation support.
What it is
KPV is the C-terminal fragment of alpha-MSH, studied for its role in inflammatory signaling. It is used inside a defined cycle rather than as an open-ended daily supplement.
What it is used for
Gut-related inflammation and skin or barrier-support goals, usually alongside broader nutrition and recovery work rather than instead of it.
How a protocol is structured
Run in a defined cycle with a check-in partway through, with route and duration selected by the prescribing provider.
What to expect
Inflammation-oriented changes are gradual and are best judged across a full cycle rather than week to week.
Common questions
What is KPV?
KPV is the three amino acid C-terminal fragment of alpha-MSH, lysine-proline-valine. The interest in it comes from preclinical work showing the fragment retains anti-inflammatory signaling without the pigmentation effects of the full alpha-MSH molecule.
What is the evidence behind it?
Cell and animal models, particularly in colitis and skin inflammation. There are no published randomized controlled trials in humans, which puts it earlier on the evidence curve than the peptides with named trial programs. That is worth saying plainly before anyone starts one.
Is it taken orally or by injection?
Both routes come up, and which is appropriate depends on whether the target is the gut lining or something more systemic. That decision belongs to the prescribing provider, not to a product page.
Is KPV orderable right now?
KPV is in our catalog rather than on our current order list. If it is relevant to your case, it is confirmed at consult with the provider network.